Concepts (193)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Peptide Fragments | 26 | 2020 | 398 | 3.810 |
Why?
|
| Angiotensin I | 25 | 2020 | 240 | 3.650 |
Why?
|
| Angiotensin II | 14 | 2015 | 243 | 1.970 |
Why?
|
| Peptidyl-Dipeptidase A | 10 | 2017 | 132 | 0.990 |
Why?
|
| Antihypertensive Agents | 5 | 2015 | 351 | 0.920 |
Why?
|
| Neovascularization, Pathologic | 2 | 2012 | 82 | 0.720 |
Why?
|
| Cell Proliferation | 3 | 2012 | 599 | 0.700 |
Why?
|
| Fibroblasts | 2 | 2012 | 112 | 0.700 |
Why?
|
| MAP Kinase Signaling System | 5 | 2015 | 61 | 0.640 |
Why?
|
| Antineoplastic Agents | 4 | 2020 | 607 | 0.640 |
Why?
|
| Lung Neoplasms | 4 | 2011 | 409 | 0.640 |
Why?
|
| Rats | 17 | 2020 | 1596 | 0.600 |
Why?
|
| Animals | 26 | 2020 | 7466 | 0.570 |
Why?
|
| Myocytes, Cardiac | 2 | 2008 | 86 | 0.560 |
Why?
|
| Dual Specificity Phosphatase 1 | 5 | 2015 | 29 | 0.550 |
Why?
|
| Muscle, Smooth, Vascular | 2 | 2008 | 63 | 0.530 |
Why?
|
| Renin-Angiotensin System | 5 | 2012 | 178 | 0.520 |
Why?
|
| Proto-Oncogene Proteins | 5 | 2009 | 85 | 0.500 |
Why?
|
| Blood Pressure | 6 | 2015 | 845 | 0.490 |
Why?
|
| Adenocarcinoma | 3 | 2012 | 311 | 0.480 |
Why?
|
| Xenograft Model Antitumor Assays | 4 | 2012 | 114 | 0.480 |
Why?
|
| Cells, Cultured | 8 | 2012 | 833 | 0.460 |
Why?
|
| Muscle, Skeletal | 2 | 2016 | 517 | 0.450 |
Why?
|
| Hypertension | 4 | 2015 | 957 | 0.450 |
Why?
|
| Vascular Endothelial Growth Factor A | 3 | 2012 | 111 | 0.450 |
Why?
|
| Rats, Sprague-Dawley | 11 | 2020 | 745 | 0.440 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-1 | 1 | 2012 | 7 | 0.420 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 6 | 2015 | 43 | 0.420 |
Why?
|
| Carboxypeptidases | 3 | 2005 | 21 | 0.380 |
Why?
|
| Angiotensins | 1 | 2011 | 42 | 0.380 |
Why?
|
| Mitogen-Activated Protein Kinases | 2 | 2008 | 37 | 0.370 |
Why?
|
| Autonomic Nervous System | 1 | 2011 | 43 | 0.370 |
Why?
|
| RNA, Messenger | 11 | 2009 | 508 | 0.360 |
Why?
|
| Ventricular Remodeling | 4 | 2011 | 58 | 0.360 |
Why?
|
| Prostatic Neoplasms | 2 | 2012 | 470 | 0.360 |
Why?
|
| Cell Division | 3 | 2005 | 95 | 0.360 |
Why?
|
| Gene Expression Regulation | 4 | 2012 | 494 | 0.330 |
Why?
|
| Mitogen-Activated Protein Kinase Phosphatases | 1 | 2008 | 4 | 0.320 |
Why?
|
| Fibrosis | 5 | 2016 | 118 | 0.320 |
Why?
|
| Receptors, G-Protein-Coupled | 5 | 2009 | 85 | 0.320 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2008 | 72 | 0.310 |
Why?
|
| Angiotensin II Type 1 Receptor Blockers | 6 | 2008 | 65 | 0.300 |
Why?
|
| Heart Ventricles | 1 | 2008 | 135 | 0.300 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 4 | 2012 | 36 | 0.290 |
Why?
|
| Medulla Oblongata | 4 | 2012 | 51 | 0.280 |
Why?
|
| Phosphorylation | 4 | 2015 | 230 | 0.260 |
Why?
|
| Astrocytes | 1 | 2005 | 58 | 0.260 |
Why?
|
| Heart Diseases | 2 | 2020 | 116 | 0.250 |
Why?
|
| Losartan | 6 | 2008 | 64 | 0.250 |
Why?
|
| Cell Line, Tumor | 5 | 2012 | 725 | 0.250 |
Why?
|
| Animals, Newborn | 3 | 2012 | 115 | 0.240 |
Why?
|
| Mice, Nude | 5 | 2012 | 290 | 0.240 |
Why?
|
| Myocardium | 4 | 2020 | 186 | 0.230 |
Why?
|
| Vasoconstrictor Agents | 3 | 2015 | 63 | 0.230 |
Why?
|
| Brain | 1 | 2011 | 950 | 0.230 |
Why?
|
| Imidazoles | 4 | 2008 | 91 | 0.210 |
Why?
|
| Cardiomegaly | 1 | 2011 | 31 | 0.200 |
Why?
|
| Mice | 7 | 2016 | 2475 | 0.200 |
Why?
|
| Endothelin-1 | 2 | 2012 | 18 | 0.180 |
Why?
|
| Renin | 4 | 2012 | 109 | 0.170 |
Why?
|
| Cyclooxygenase 2 | 2 | 2012 | 47 | 0.170 |
Why?
|
| Doxorubicin | 1 | 2020 | 82 | 0.170 |
Why?
|
| Rats, Inbred Lew | 4 | 2015 | 117 | 0.170 |
Why?
|
| Antioxidants | 1 | 2020 | 114 | 0.170 |
Why?
|
| Baroreflex | 2 | 2011 | 84 | 0.160 |
Why?
|
| Flavonoids | 2 | 2008 | 18 | 0.160 |
Why?
|
| Male | 15 | 2020 | 19193 | 0.160 |
Why?
|
| Signal Transduction | 3 | 2012 | 687 | 0.160 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 2 | 2012 | 31 | 0.160 |
Why?
|
| Protein Kinase Inhibitors | 2 | 2008 | 85 | 0.160 |
Why?
|
| Oxidative Stress | 2 | 2012 | 231 | 0.150 |
Why?
|
| Dipeptidyl-Peptidases and Tripeptidyl-Peptidases | 1 | 2017 | 6 | 0.150 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 3 | 2008 | 135 | 0.150 |
Why?
|
| Amino Acid Substitution | 1 | 2017 | 39 | 0.150 |
Why?
|
| Transforming Growth Factor beta | 2 | 2015 | 64 | 0.140 |
Why?
|
| Tetrazoles | 3 | 2006 | 61 | 0.140 |
Why?
|
| Hypertension, Renal | 2 | 2006 | 29 | 0.140 |
Why?
|
| Sarcoma, Experimental | 1 | 2016 | 4 | 0.130 |
Why?
|
| Spasm | 1 | 2016 | 6 | 0.130 |
Why?
|
| Smad2 Protein | 1 | 2015 | 6 | 0.130 |
Why?
|
| Arterioles | 1 | 2015 | 13 | 0.130 |
Why?
|
| Connective Tissue Growth Factor | 1 | 2015 | 7 | 0.130 |
Why?
|
| Smad3 Protein | 1 | 2015 | 10 | 0.130 |
Why?
|
| Humans | 11 | 2017 | 32020 | 0.120 |
Why?
|
| Chronic Disease | 1 | 2015 | 401 | 0.110 |
Why?
|
| Pregnancy Proteins | 1 | 2012 | 13 | 0.100 |
Why?
|
| Heart Rate | 2 | 2020 | 334 | 0.100 |
Why?
|
| Osteoclasts | 1 | 2012 | 22 | 0.100 |
Why?
|
| Blotting, Western | 2 | 2010 | 292 | 0.100 |
Why?
|
| Pyridines | 3 | 2005 | 76 | 0.090 |
Why?
|
| Lung Diseases, Interstitial | 1 | 2010 | 8 | 0.090 |
Why?
|
| Collagen | 1 | 2012 | 225 | 0.090 |
Why?
|
| Carcinoma, Ductal, Breast | 1 | 2010 | 30 | 0.090 |
Why?
|
| DNA | 1 | 2012 | 228 | 0.090 |
Why?
|
| Oligonucleotides, Antisense | 2 | 2012 | 30 | 0.090 |
Why?
|
| Sodium Chloride, Dietary | 1 | 2009 | 28 | 0.090 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2009 | 36 | 0.090 |
Why?
|
| Chorioallantoic Membrane | 1 | 2009 | 4 | 0.090 |
Why?
|
| Injections, Subcutaneous | 1 | 2009 | 35 | 0.080 |
Why?
|
| Chick Embryo | 1 | 2009 | 74 | 0.080 |
Why?
|
| Valine | 2 | 2006 | 14 | 0.080 |
Why?
|
| Bone Marrow Cells | 2 | 2012 | 121 | 0.080 |
Why?
|
| Atrial Natriuretic Factor | 1 | 2008 | 10 | 0.080 |
Why?
|
| Butadienes | 1 | 2008 | 8 | 0.080 |
Why?
|
| Vanadates | 1 | 2008 | 2 | 0.080 |
Why?
|
| Okadaic Acid | 1 | 2008 | 4 | 0.080 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2009 | 261 | 0.080 |
Why?
|
| Nitriles | 1 | 2008 | 23 | 0.080 |
Why?
|
| Neovascularization, Physiologic | 1 | 2009 | 110 | 0.080 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2009 | 170 | 0.080 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2008 | 80 | 0.080 |
Why?
|
| Leucine | 1 | 2008 | 20 | 0.080 |
Why?
|
| Endothelial Cells | 1 | 2009 | 189 | 0.080 |
Why?
|
| Solitary Nucleus | 1 | 2008 | 34 | 0.080 |
Why?
|
| Kinetics | 2 | 2006 | 209 | 0.080 |
Why?
|
| Disease Models, Animal | 4 | 2016 | 1017 | 0.070 |
Why?
|
| Models, Genetic | 1 | 2006 | 94 | 0.070 |
Why?
|
| Reactive Oxygen Species | 2 | 2020 | 157 | 0.070 |
Why?
|
| Cerebellum | 1 | 2005 | 26 | 0.070 |
Why?
|
| Malondialdehyde | 2 | 2020 | 11 | 0.060 |
Why?
|
| Arachidonic Acid | 1 | 2004 | 35 | 0.060 |
Why?
|
| Culture Media | 1 | 2004 | 47 | 0.060 |
Why?
|
| DNA Replication | 1 | 2004 | 34 | 0.060 |
Why?
|
| Cardiomyopathy, Hypertrophic | 1 | 2004 | 4 | 0.060 |
Why?
|
| Stromal Cells | 1 | 2004 | 84 | 0.060 |
Why?
|
| Aging | 1 | 2011 | 945 | 0.060 |
Why?
|
| Breast Neoplasms | 1 | 2010 | 761 | 0.060 |
Why?
|
| Prostaglandins | 1 | 2003 | 14 | 0.060 |
Why?
|
| Cyclic AMP | 1 | 2003 | 47 | 0.060 |
Why?
|
| Receptors, Angiotensin | 1 | 2003 | 61 | 0.050 |
Why?
|
| Neoplasms | 1 | 2009 | 692 | 0.050 |
Why?
|
| Pregnancy | 1 | 2005 | 994 | 0.050 |
Why?
|
| Drug Interactions | 1 | 2011 | 79 | 0.050 |
Why?
|
| Up-Regulation | 1 | 2011 | 189 | 0.050 |
Why?
|
| Catalase | 1 | 2020 | 15 | 0.040 |
Why?
|
| Superoxide Dismutase | 1 | 2020 | 46 | 0.040 |
Why?
|
| Female | 4 | 2020 | 19950 | 0.040 |
Why?
|
| Mitral Valve | 1 | 2020 | 33 | 0.040 |
Why?
|
| Myocardial Infarction | 1 | 2004 | 485 | 0.040 |
Why?
|
| Kidney | 1 | 2003 | 515 | 0.040 |
Why?
|
| Protein Stability | 1 | 2017 | 25 | 0.040 |
Why?
|
| Neprilysin | 2 | 2008 | 31 | 0.040 |
Why?
|
| Animals, Genetically Modified | 2 | 2006 | 66 | 0.030 |
Why?
|
| Muscle Neoplasms | 1 | 2016 | 8 | 0.030 |
Why?
|
| Mice, Inbred Strains | 1 | 2016 | 47 | 0.030 |
Why?
|
| Lisinopril | 2 | 2006 | 26 | 0.030 |
Why?
|
| Hindlimb | 1 | 2016 | 54 | 0.030 |
Why?
|
| Biopsy, Needle | 1 | 2016 | 95 | 0.030 |
Why?
|
| Reference Values | 1 | 2016 | 247 | 0.030 |
Why?
|
| Random Allocation | 1 | 2016 | 220 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2009 | 629 | 0.030 |
Why?
|
| Analysis of Variance | 1 | 2016 | 464 | 0.030 |
Why?
|
| Sensitivity and Specificity | 1 | 2016 | 594 | 0.030 |
Why?
|
| Receptor, Angiotensin, Type 1 | 2 | 2004 | 65 | 0.030 |
Why?
|
| Immunohistochemistry | 1 | 2016 | 532 | 0.030 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 2012 | 14 | 0.030 |
Why?
|
| Ion Channels | 1 | 2012 | 24 | 0.030 |
Why?
|
| Rats, Transgenic | 1 | 2012 | 47 | 0.030 |
Why?
|
| Mice, SCID | 1 | 2012 | 71 | 0.030 |
Why?
|
| Angiotensinogen | 1 | 2012 | 59 | 0.030 |
Why?
|
| Mitochondrial Proteins | 1 | 2012 | 66 | 0.030 |
Why?
|
| Neoplasm Metastasis | 1 | 2012 | 221 | 0.020 |
Why?
|
| Bone Neoplasms | 1 | 2012 | 111 | 0.020 |
Why?
|
| Mitochondria | 1 | 2012 | 186 | 0.020 |
Why?
|
| Immunoenzyme Techniques | 1 | 2010 | 52 | 0.020 |
Why?
|
| Fibronectins | 1 | 2010 | 36 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2010 | 91 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 1 | 2010 | 168 | 0.020 |
Why?
|
| Rats, Inbred SHR | 1 | 2009 | 31 | 0.020 |
Why?
|
| Peptides | 1 | 2009 | 119 | 0.020 |
Why?
|
| Membranes | 1 | 2008 | 10 | 0.020 |
Why?
|
| Phenylephrine | 1 | 2008 | 28 | 0.020 |
Why?
|
| Aged | 2 | 2012 | 10338 | 0.020 |
Why?
|
| Cell Growth Processes | 1 | 2007 | 8 | 0.020 |
Why?
|
| Models, Biological | 1 | 2009 | 391 | 0.020 |
Why?
|
| Animals, Congenic | 1 | 2006 | 14 | 0.020 |
Why?
|
| Crosses, Genetic | 1 | 2006 | 20 | 0.020 |
Why?
|
| Middle Aged | 2 | 2012 | 11866 | 0.020 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2006 | 32 | 0.020 |
Why?
|
| Podocytes | 1 | 2006 | 20 | 0.020 |
Why?
|
| Kidney Glomerulus | 1 | 2006 | 30 | 0.020 |
Why?
|
| Albuminuria | 1 | 2006 | 181 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2009 | 1831 | 0.020 |
Why?
|
| Macrophage Colony-Stimulating Factor | 1 | 2004 | 5 | 0.020 |
Why?
|
| Receptor, Angiotensin, Type 2 | 1 | 2004 | 22 | 0.020 |
Why?
|
| Enzyme Induction | 1 | 2004 | 32 | 0.010 |
Why?
|
| Ligation | 1 | 2004 | 56 | 0.010 |
Why?
|
| Macaca fascicularis | 1 | 2004 | 397 | 0.010 |
Why?
|
| Coronary Vessels | 1 | 2004 | 160 | 0.010 |
Why?
|
| Protein Binding | 1 | 2003 | 201 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2009 | 4000 | 0.010 |
Why?
|
| Time Factors | 1 | 2006 | 2152 | 0.010 |
Why?
|
| Adult | 1 | 2009 | 9363 | 0.010 |
Why?
|